Macao suspends inoculation of mRNA COVID-19 vaccines made in Germany due to package flaw
MACAO -- China's Macao Special Administrative Region on Wednesday suspended inoculation of mRNA COVID-19 vaccines made in Germany due to package flaws related to the vial tops, according to the Novel Coronavirus Response and Coordination Center of the Macao SAR.
An investigation has been launched into the cause of the problem by BioNTech and Fosun Pharma, developers of the vaccine, according to the center.
The developers so far do not have the reason to believe the vaccines have safety risks and the suspension of inoculation during the investigation is out of caution, said the center.
Local residents who have made reservations for inoculation of the vaccine do not need to visit inoculation facilities until further notice, the center said.
The first batch of mRNA vaccines were delivered to Macao on Feb 27. Inoculation started on March 3.
- Public security tech expo showcases innovation, global cooperation
- Train tickets go on sale for National Day, Mid-Autumn holidays
- China's latest job classification update highlights digital and green professions
- China recognizes 11 new occupations as new industries create fresh roles
- Jiangsu encourages universities to buy commodity housing for dormitories
- Fujian man, 99, recalls Red Army's lasting impact






























